- Home
- KROS vs OLP Comparison
KROS vs OLP Comparison
Compare KROS & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- OLP
- Stock Information
- Founded
- KROS 2015
- OLP 1982
- Country
- KROS United States
- OLP United States
- Employees
- KROS N/A
- OLP N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- OLP Real Estate Investment Trusts
- Sector
- KROS Health Care
- OLP Real Estate
- Exchange
- KROS Nasdaq
- OLP Nasdaq
- Market Cap
- KROS 558.9M
- OLP 569.9M
- IPO Year
- KROS 2020
- OLP N/A
- Fundamental
- Price
- KROS $14.68
- OLP $24.27
- Analyst Decision
- KROS Buy
- OLP Strong Buy
- Analyst Count
- KROS 13
- OLP 1
- Target Price
- KROS $20.63
- OLP $28.00
- AVG Volume (30 Days)
- KROS 468.5K
- OLP 78.9K
- Earning Date
- KROS 08-06-2025
- OLP 08-05-2025
- Dividend Yield
- KROS N/A
- OLP 7.46%
- EPS Growth
- KROS N/A
- OLP N/A
- EPS
- KROS 0.11
- OLP 1.35
- Revenue
- KROS $214,713,000.00
- OLP $92,152,000.00
- Revenue This Year
- KROS $5,006.76
- OLP $11.87
- Revenue Next Year
- KROS N/A
- OLP $4.72
- P/E Ratio
- KROS $133.63
- OLP $17.91
- Revenue Growth
- KROS 91657.70
- OLP 3.31
- 52 Week Low
- KROS $9.12
- OLP $22.32
- 52 Week High
- KROS $72.37
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- KROS 64.67
- OLP 48.30
- Support Level
- KROS $13.26
- OLP $23.79
- Resistance Level
- KROS $14.68
- OLP $24.32
- Average True Range (ATR)
- KROS 0.41
- OLP 0.49
- MACD
- KROS 0.12
- OLP -0.02
- Stochastic Oscillator
- KROS 89.35
- OLP 36.86
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.